The role of histology on survival of triple negative breast cancer.

被引：1
|
作者：
Parise, Carol [1 ]
Caggiano, Vincent [1 ]
机构：
[1] Sutter Inst Med Res, Sacramento, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e12590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12590
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Association of intraoperative opioids with improved recurrence-free survival in triple-negative breast cancer.
    Montagna, Giacomo
    Hannum, Margaret L.
    Tan, Kay See
    Plitas, George
    McCormick, Patrick J.
    Fischer, Gregory W.
    Morrow, Monica
    Mincer, Joshua S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Triple Negative Breast Cancer Has Worse Overall Survival and Cause-Specific Survival Than Non-Triple Negative Breast Cancer
    Li, Xiaoxian
    Yang, Jing
    Peng, Limin
    Sahin, Aysegul A.
    Huo, Lei
    Ward, Kevin C.
    O'Regan, Ruth
    Torres, Mylin A.
    Meisel, Jane L.
    [J]. MODERN PATHOLOGY, 2017, 30 : 54A - 54A
  • [33] Triple Negative Breast Cancer Has Worse Overall Survival and Cause-Specific Survival Than Non-Triple Negative Breast Cancer
    Li, Xiaoxian
    Yang, Jing
    Peng, Limin
    Sahin, Aysegul A.
    Huo, Lei
    Ward, Kevin C.
    O'Regan, Ruth
    Torres, Mylin A.
    Meisel, Jane L.
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 54A - 54A
  • [34] Comprehensive kinome activity mapping of triple-negative breast cancer.
    Koemans, Nina M.
    Van der Borden, Carolien L.
    Mori, Miki
    Pan, Bo
    Wang, Changjun
    Van 't Veer, Laura J.
    Coppe, Jean-Philippe
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 44 - 44
  • [35] Inhibiting fatty acid synthase in operable triple negative breast cancer.
    Sardesai, Sagar D.
    Thomas, Alexandra
    Gallagher, Christopher
    Lynce, Filipa
    Ottaviano, Yvonne Lynn
    Ballinger, Tarah Jean
    Schneider, Bryan P.
    Storniolo, Anna Maria
    Bauchle, Amber
    Althouse, Sandra K.
    Perkins, Susan
    Zhang, Jian-Ting
    Miller, Kathy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Investigating mitotic kinesins as therapeutic targets for triple negative breast cancer.
    Cindy, F.
    Marquis, C.
    Wood, L.
    Anker, C. J.
    Howe, A. K.
    Clayton, J. E.
    Stumpff, J.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [37] Preclinical evaluation of ERX-41 in triple negative breast cancer.
    Viswanadhapalli, Suryavathi
    Liu, Xihui
    Ma, Shi-Hong
    Lee, Tae-Kyung
    Li, Mengxing
    Tang, Weiwei
    Liu, Junhao
    Li, Xiaonan
    Sareddy, Gangadhara R.
    Tekmal, Rajeshwar Rao
    Ahn, Jung-Mo
    Vadlamudi, Ratna K.
    Raj, Ganesh V.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [38] Efficacy study of metronomic chemotherapy in triple negative metastatic breast cancer.
    Srinivasa, B. J.
    Kalegowda, Viveka Belathur
    Badarkhe, Girish
    Sridhar, P. S.
    Khanderia, Mansi
    Tousif, T.
    Lalkota, Bhanu
    Kodad, Shruthy
    Musheb, Mohamed
    Sapkota, Sulav
    Nayak, Radheshyam
    Ajaikumar, Basavalinga S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Characterizing the gut microbiome of patients with triple-negative breast cancer.
    Swoboda, April T.
    Sharma, Anukriti
    Olopade, Olufunmilayo I.
    Nanda, Rita
    Gilbert, Jack
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Prognostic significance of NLR kinetics in operable triple negative breast cancer.
    Ganta, Ranga Raman
    Nasaka, Srividya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345